Alvotech (NASDAQ:ALVO) Sees Large Drop in Short Interest - MarketBeat
2 hours ago • Google News
Alvotech (ALVO)
US$ 00%
Price Chart
Key Statistics
Market Cap
$ 2.48B
P/E Ratio
34.61
Revenue (TTM)
$ 562.48M
Volume
0
52W High
$ 13.70
52W Low
$ 7.35
Dividend Yield
0.00%
Beta
0.10
Technicals
50-Day MA
8.5486
200-Day MA
10.3052
52 Week High
13.7
52 Week Low
7.35
About ALVO
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders.
Employees
1012
Headquarters
Luxembourg City, Luxembourg
CEO
Mr. Robert Wessman
Latest News
ALVO Stock Trades Near 52-Week Low: Should You Buy, Hold or Sell? - Yahoo Finance
1 weeks ago • Google News